美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=SITAGLIPTIN PHOSPHATE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
SITAGLIPTIN PHOSPHATE 202473 001 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL EQ 25MG BASE No 2012/10/10 (TA) MYLAN PHARMS INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202473 002 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL EQ 50MG BASE No 2012/10/10 (TA) MYLAN PHARMS INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202473 003 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL EQ 100MG BASE No 2012/10/10 (TA) MYLAN PHARMS INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202387 001 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL EQ 25MG BASE No 2013/01/30 (TA) SANDOZ INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202387 002 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL EQ 50MG BASE No 2013/01/30 (TA) SANDOZ INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202387 003 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL EQ 100MG BASE No 2013/01/30 (TA) SANDOZ INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202423 001 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL 25MG No 2013/04/11 (TA) SUN PHARMA GLOBAL None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202423 002 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL 50MG No 2013/04/11 (TA) SUN PHARMA GLOBAL None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202423 003 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL 100MG No 2013/04/11 (TA) SUN PHARMA GLOBAL None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202425 001 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL 25MG No 2014/02/18 (TA) APOTEX INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202425 002 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL 50MG No 2014/02/18 (TA) APOTEX INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202425 003 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL 100MG No 2014/02/18 (TA) APOTEX INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202327 001 ANDA SITAGLIPTIN PHOSPHATE TABLET;ORAL 25MG No 2014/04/15 (TA) WATSON LABS INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202327 002 ANDA SITAGLIPTIN PHOSPHATE TABLET;ORAL 50MG No 2014/04/15 (TA) WATSON LABS INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202327 003 ANDA SITAGLIPTIN PHOSPHATE TABLET;ORAL 100MG No 2014/04/15 (TA) WATSON LABS INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202487 001 ANDA SITAGLIPTIN PHOSPHATE TABLET;ORAL 25MG No 2015/02/23 (TA) TEVA PHARMS USA None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202487 002 ANDA SITAGLIPTIN PHOSPHATE TABLET;ORAL 50MG No 2015/02/23 (TA) TEVA PHARMS USA None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202487 003 ANDA SITAGLIPTIN PHOSPHATE TABLET;ORAL 100MG No 2015/02/23 (TA) TEVA PHARMS USA None (Tentative Approval)
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE 204144 001 ANDA METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE TABLET, EXTENDED RELEASE;ORAL 500MG; EQ 50MG BASE No 2015/04/21 (TA) ANCHEN PHARMS None (Tentative Approval)
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE 204144 002 ANDA METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE TABLET, EXTENDED RELEASE;ORAL 1GM; EQ 50MG BASE No 2015/04/21 (TA) ANCHEN PHARMS None (Tentative Approval)
药品名称,活性成分,申请号搜索 高级检索
©2006-2019 DrugFuture->U.S. FDA Drugs Database